Oral cromolyn therapy in patients with food allergy: a preliminary report.

In a preliminary double-blind, placebo controlled, crossover study, 10 out of 16 patients (62.5%) had remissions in acute symptoms of food allergy with oral cromolyn therapy. The effective dosage for each patient had to be sought individually. No serious side effects were encountered.

RCT Entities:   Population Interventions Outcomes